Abstract #3525, Davis, DW et. Al., “Circulating Tumor and Endothelial Cells as Pharmacodynamic Biomarkers in a Phase I Clinical Trial of Intravenous Bevacizumab in Combination with Escalating Doses of Oral Cediranib for Patients with Advanced Malignancies”

Learn More